Because oxidative stress can be an upstream effector of caspase activation [38], and is suppressed by IGF-1 in breast cancer cells [39], we further determined the levels of ROS in cells undergoing the hormonal treatments in medium supplemented with or devoid of IGF-1. Here, IGF1 is linked to breast cancer.